Last reviewed · How we verify

NCT05807607

Study of Lower-limb Phantom Pain Syndrome Using Peripheral Nerve and Spinal Cord Stimulation

Status unknown NA Last updated 11 April 2023
What this trial tests

NA trial testing Implantation of PNS electrodes during surgery, mapping to select sites with the best effect and daily modulation. in Phantom Limb Pain in 10 participants. Status unknown.

Timeline
17 November 2022
Primary endpoint
1 November 2025
1 December 2025

Quick facts

Lead sponsorArtur Biktimirov
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposetreatment
Enrollment10
Start date17 November 2022
Primary completion1 November 2025
Estimated completion1 December 2025
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Artur Biktimirov

Who can join

Adults 18 to 65, any sex, with Phantom Limb Pain or Phantom Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Summary: The purpose of this study is to evaluate the effectiveness of neuromodulation for relief of phantom limb pain (PLP) using peripheral nerve (PNS) and spinal cord (SCS) stimulation with implantable electrodes. The researchers expect that PLP in patients with lower limb amputation will be relieved by peripheral nerve and the spinal cord stimulation. The possibility of finding EEG biomarkers for phantom pain will be explored.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Phantom Limb Pain

Currently open trials in the same condition.

Other Artur Biktimirov trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05807607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing